Guido Oelkers lyfter också fram att Baxter och Gambro är två företag som kompletterar varandras produktportföljer inom dialysområdet på ett utmärkt sätt.

Så säger vd Guido Oelkers om hur bolaget avser att bli ett ledande bolag inom särläkemedel. "Vi avser att bli en större spelare men främst inom Hemofili och Specialty Care och det ser vi över, samtidigt har vi en bra tillväxt i många delar av bolaget som hjälper oss på vägen", säger Guido Oelkers i en intervju med Nyhetsbyrån Direkt och fortsätter:

* Oelkers joins Sobi from his previous role as CEO at BSN Medical GmbH. Discover Thomson Reuters. Directory of sites Login BRIEF-Sobi appoints Guido Oelkers as new CEO. Guido Oelkers was born in 1965 and holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from South Bank University, London. He complemented his postgraduate studies in Economics at London School of Economics and Political Science.

Jag ser fram emot att jobba tillsammans,” säger Dr Guido Oelkers, VD på BSN medical. Det sade Sobis vd Guido Oelkers under torsdagens telefonkonferens i samband med bokslutet för 2020 och uppger att bolaget befinner sig i en övergångsfas. Endast 5 till 10 procent av den framtida tillväxten för bolaget väntas komma från kärnverksamheten inom hematologi och immunologi. Guido Oelkers joins Sobi from his previous role as CEO at BSN Medical GmbH. He has extensive experience from pharmaceutical and health care companies including a role as President and CEO of the GUIDO OELKERS. Sobi tar klivet in bland större läkemedelsbolag.

Guido Oelkers is President & Chief Executive Officer at Swedish Orphan Biovitrum AB. View Guido Oelkers’s professional profile on Relationship Science, the database of decision makers.

Website. sobi.com Sobi Reviews.

Det sade Sobis vd Guido Oelkers under onsdagens telefonkonferens. Runt en tredjedel till 40 procent av tillväxtökningen inom hemofili kan dock förklaras av ökade lager. Medan försäljningen av hemofililäkemedlen Elocta och Alprolix under det första kvartalet inte nådde upp till förväntningarna enligt Infronts konsensus

“Sobi ist ein einzigartiges Unternehmen im Bereich der seltenen Erkrankungen", so der neue CEO. Mit einem starken Vermächtnis begebe sich das Unternehmen auf eine spannende Reise in die Zukunft. Guido Oelkers appointed President and CEO at Sobi Thu, May 04, 2017 08:00 CET. Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that Guido Oelkers has been appointed President and Chief Executive Officer effective as of 22 May 2017, succeeding Geoffrey McDonough.

Se personens officiella befattningar (3) och relationer (21) i näringslivet - och vilka branscher 15 Apr 2017 Guido Oelkers was born in 1965 and holds a PhD in Strategic Management from the University of South Australia and a Master of Economics Guido Oelkers.
Produktdesign malmö

Really appreciate your interest in Sobi, and wish you a great day, yes. Talk to you soon.

Head of R&D and 18 Feb 2021 Guido Oelkers, CEO and President: "2020 was a year of extreme challenges but also great opportunities.
Modersmålslärare utbildning stockholm

små företagare i sverige
revision intern kontroll
bolan utan fast anstallning sbab
cicero traitors
freeport kungsback
tryckeri halmstad kläder

4 May 2017 Guido Oelkers joins Sobi from his previous role as CEO at BSN Medical GmbH. Guido Oelkers was also a member of the Board of Directors for

Guido Oelkers is President CEO of Swedish Orphan Biovit. Guido Oelkers corporate profile, background and performance evaluation including other Swedish Orphan executives Guido Oelkers was also a member of the Board of Directors for Meda. Guido Oelkers was born in 1965 and holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from South Bank University, London. He complemented his postgraduate studies in Economics at London School of Economics and Political Science.

12 Jun 2019 "We will continue to increase our R&D spend in late-stage development,” Sobi CEO Guido Oelkers said in a statement. Sobi plans to buy in

Chief Financial Officer. Anne Marie De Jonge Schuermans. Head of Technical Operations. 26 Jun 2020 Guido Oelkers resigned from his position on the Supervisory Board of Sartorius AG at the end of 2019. Prof. Ebsworth has extensive expertise Swedish Orphan Biovitrum AB (BIOVF) CEO Guido Oelkers on Q3 2020 Results - Earnings Call Transcript · SA TranscriptsFri, Oct. 23, 2020.

Henrik Stenqvist. Chief Financial Officer. Anne Marie De Jonge Schuermans. Head of Technical Operations. 26 Jun 2020 Guido Oelkers resigned from his position on the Supervisory Board of Sartorius AG at the end of 2019. Prof.